<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03268707</url>
  </required_header>
  <id_info>
    <org_study_id>PV5361</org_study_id>
    <nct_id>NCT03268707</nct_id>
  </id_info>
  <brief_title>Influence of an Innovative Telemetric Smartphone Application on Re-hospitalization</brief_title>
  <acronym>TRACE-AF</acronym>
  <official_title>Influence of an Innovative Telemetric Smartphone Application on Re-hospitalization And Quality of Life After Cryoballoon Pulmonary vEin Isolation in Patients With Paroxysmal Atrial Fibrillation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universitätsklinikum Hamburg-Eppendorf</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universitätsklinikum Hamburg-Eppendorf</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      A randomized, open, mono-centric pilot study to investigate the influence of an innovative
      telemetric smartphone application on re-hospitalization and quality of life after cryoballoon
      pulmonary vein isolation in patients with paroxysmal atrial fibrillation.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The telemetric smartphone application includes a digitized medical record, a mobile ECG
      device and a 24-hour on call service by a cardiologist. The hypothesis is that the use of a
      telemetric smartphone application can reduce re-hospitalization in patients after cryoballoon
      pulmonary vein isolation. Secondary endpoints are quality of life measurements, health care
      cost calculations and recurrences of atrial fibrillation after ablation. All patients will
      undergo ablation and will be randomized into two groups: 1) conventional follow up with
      outpatient visits 6 and 12 months after ablation compared to 2) a structured follow up with
      the smartphone application, a mobile ECG device (patients will be able to send in as many
      ECGs as wanted), up to three phone calls with a cardiologist (24-hour on call service) as
      well as outpatient visits 6 and 12 months after cryo-ablation.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 15, 2017</start_date>
  <completion_date type="Anticipated">June 30, 2020</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Sequential Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Rehospitalization</measure>
    <time_frame>in 12 months</time_frame>
    <description>Rate of rehospitalization after cryoballoon pulmonary vein isolation in patients with paroxysmal atrial fibrillation</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Quality of Life</measure>
    <time_frame>in 12 months</time_frame>
    <description>Quality of Life questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Anxiety</measure>
    <time_frame>in 12 months</time_frame>
    <description>Quality of Life questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Health care costs</measure>
    <time_frame>in 12 months</time_frame>
    <description>Rate of rehospitalization after cryoballoon pulmonary vein isolation in patients with paroxysmal atrial fibrillation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of atrial fibrillation recurrences</measure>
    <time_frame>in 12 months</time_frame>
    <description>Rate of rehospitalization after cryoballoon pulmonary vein isolation in patients with paroxysmal atrial fibrillation</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Paroxysmal Atrial Fibrillation</condition>
  <arm_group>
    <arm_group_label>Conventional follow up</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Conventional follow up at physician practice</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Telemetric smartphone application</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Structured follow up with a telemetric smartphone application</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Telemetric smartphone application</intervention_name>
    <description>Structured follow up with a telemetric smartphone application</description>
    <arm_group_label>Telemetric smartphone application</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Conventional follow up</intervention_name>
    <description>Conventional follow up at physician practice</description>
    <arm_group_label>Conventional follow up</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age &gt; 18 years

          -  Written informed consent

          -  symptomatic paroxysmal atrial fibrillation (at least two episodes within 3 months
             prior to ablation)

          -  cryoballoon pulmonary vein isolation

          -  possession of a compatible smartphone

        Exclusion Criteria:

          -  Age &lt; 18 years

          -  persistent or permanent atrial fibrillation (AF)

          -  prior catheter or surgical ablation of AF

          -  pregnant females

          -  contraindication for oral anticoagulation

          -  manifest hyper-/hypothyroidism

          -  no intention to cooperate

          -  alcoholism
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Stephan Willems, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Universitaeres Herzzentrum Hamburg GmbH</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Melanie Gunawardene, MD</last_name>
    <phone>004940741054120</phone>
    <email>m.gunawardene@uke.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Stephan Willems, MD</last_name>
    <phone>004940741054120</phone>
    <email>willems@uke.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Universitätsklinikum Hamburg-Eppendorf</name>
      <address>
        <city>Hamburg</city>
        <zip>20246</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Melanie Gunawardene</last_name>
      <phone>40741059471</phone>
      <email>m.gunawardene@uke.de</email>
    </contact>
    <contact_backup>
      <last_name>Stephan Willems</last_name>
      <phone>40741059471</phone>
      <email>willems@uke.de</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>August 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 2, 2017</study_first_submitted>
  <study_first_submitted_qc>August 28, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">August 31, 2017</study_first_posted>
  <last_update_submitted>August 28, 2017</last_update_submitted>
  <last_update_submitted_qc>August 28, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">August 31, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Paroxysmal Atrial Fibrillation</keyword>
  <keyword>Pulmonary Vein Isolation</keyword>
  <keyword>Telemetry Monitoring</keyword>
  <keyword>Cryoballoon ablation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atrial Fibrillation</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

